0001209191-21-003497.txt : 20210113
0001209191-21-003497.hdr.sgml : 20210113
20210113202147
ACCESSION NUMBER: 0001209191-21-003497
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210111
FILED AS OF DATE: 20210113
DATE AS OF CHANGE: 20210113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARRITY THOMAS J
CENTRAL INDEX KEY: 0001275012
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 21527244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-11
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001275012
GARRITY THOMAS J
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
1
0
0
0
Common Stock
2021-01-11
4
M
0
20000
2.24
A
244406
D
Common Stock
2021-01-11
4
S
0
20000
4.07
D
224406
D
Common Stock
2021-01-11
4
M
0
50000
1.12
A
274406
D
Common Stock
2021-01-11
4
S
0
50000
4.05
D
224406
D
Stock Option (right to buy)
2.24
2021-01-11
4
M
0
20000
0.00
D
2021-09-09
Common Stock
20000
0
D
Stock Option (right to buy)
1.12
2021-01-11
4
M
0
50000
0.00
D
2026-06-02
Common Stock
50000
0
D
The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
The options vested and became exercisable in four equal quarterly installments from the grant date of September 9, 2011.
The options vested and became exercisable in four equal quarterly installments from the grant date of June 2, 2016.
/s/Keith Muckenhirn as attorney-in-fact for Thomas J. Garrity
2021-01-13